These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 15823425

  • 1. Effects of (+/-)-huprine Y and (+/-)-huprine Z, two new anticholinesterasic drugs, on muscarinic receptors.
    Alcalá MM, Maderuelo A, Vivas NM, Camps P, Muñoz-Torrero D, Clos MV, Badia A.
    Neurosci Lett; 2005 May 06; 379(2):106-9. PubMed ID: 15823425
    [Abstract] [Full Text] [Related]

  • 2. Interaction of a new potent anticholinesterasic compound (+/-)huprine X with muscarinic receptors in rat brain.
    Roman S, Vivas NM, Badia A, Clos MV.
    Neurosci Lett; 2002 Jun 07; 325(2):103-6. PubMed ID: 12044632
    [Abstract] [Full Text] [Related]

  • 3. Expanding the multipotent profile of huprine-tacrine heterodimers as disease-modifying anti-Alzheimer agents.
    Muñoz-Torrero D, Pera M, Relat J, Ratia M, Galdeano C, Viayna E, Sola I, Formosa X, Camps P, Badia A, Clos MV.
    Neurodegener Dis; 2012 Jun 07; 10(1-4):96-9. PubMed ID: 22236498
    [Abstract] [Full Text] [Related]

  • 4. Potentiation effects of (+/-)huprine X, a new acetylcholinesterase inhibitor, on nicotinic receptors in rat cortical synaptosomes.
    Roman S, Badia A, Camps P, Clos MV.
    Neuropharmacology; 2004 Jan 07; 46(1):95-102. PubMed ID: 14654101
    [Abstract] [Full Text] [Related]

  • 5. Nicotinic-receptor potentiator drugs, huprine X and galantamine, increase ACh release by blocking AChE activity but not acting on nicotinic receptors.
    Roman S, Badia A, Camps P, Muñoz-Torrero D, Clos MV.
    Brain Res; 2005 Nov 09; 1061(2):73-9. PubMed ID: 16248990
    [Abstract] [Full Text] [Related]

  • 6. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
    Forray C, el-Fakahany EE.
    Mol Pharmacol; 1990 Jun 09; 37(6):893-902. PubMed ID: 2163015
    [Abstract] [Full Text] [Related]

  • 7. The pharmacology of novel acetylcholinesterase inhibitors, (+/-)-huprines Y and X, on the Torpedo electric organ.
    Ros E, Aleu J, Gómez de Aranda I, Muñoz-Torrero D, Camps P, Badia A, Marsal J, Solsona C.
    Eur J Pharmacol; 2001 Jun 08; 421(2):77-84. PubMed ID: 11399262
    [Abstract] [Full Text] [Related]

  • 8. Behavioural effects and regulation of PKCalpha and MAPK by huprine X in middle aged mice.
    Ratia M, Giménez-Llort L, Camps P, Muñoz-Torrero D, Clos MV, Badia A.
    Pharmacol Biochem Behav; 2010 Jun 08; 95(4):485-93. PubMed ID: 20363245
    [Abstract] [Full Text] [Related]

  • 9. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE.
    Mol Pharmacol; 1986 Jul 08; 30(1):58-68. PubMed ID: 3755217
    [Abstract] [Full Text] [Related]

  • 10. Neuroprotective effects of (+/-)-huprine Y on in vitro and in vivo models of excitoxicity damage.
    Canudas AM, Pubill D, Sureda FX, Verdaguer E, Camps P, Muñoz-Torrero D, Jiménez A, Camins A, Pallàs M.
    Exp Neurol; 2003 Apr 08; 180(2):123-30. PubMed ID: 12684026
    [Abstract] [Full Text] [Related]

  • 11. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
    Bymaster FP, Heath I, Hendrix JC, Shannon HE.
    J Pharmacol Exp Ther; 1993 Oct 08; 267(1):16-24. PubMed ID: 7901390
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of alkylating agents on the multiple muscarinic receptor subtypes linked to activation of phospholipase C by carbachol in rat brain cortical membranes.
    Sallés J, Wallace MA, Fain JN.
    J Pharmacol Exp Ther; 1993 Feb 08; 264(2):521-9. PubMed ID: 8437104
    [Abstract] [Full Text] [Related]

  • 13. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.
    Lee W, Wolfe BB.
    Mol Pharmacol; 1989 Nov 08; 36(5):749-57. PubMed ID: 2555673
    [Abstract] [Full Text] [Related]

  • 14. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 1986 May 08; 237(2):419-27. PubMed ID: 3754581
    [Abstract] [Full Text] [Related]

  • 15. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
    Flynn DD, Mash DC.
    J Pharmacol Exp Ther; 1989 Aug 08; 250(2):573-81. PubMed ID: 2760841
    [Abstract] [Full Text] [Related]

  • 16. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB, Creese I.
    Mol Pharmacol; 1986 Aug 08; 30(2):96-103. PubMed ID: 3755499
    [Abstract] [Full Text] [Related]

  • 17. Effects of serotonergic denervation on the density and plasticity of brain muscarinic receptors in the rat.
    Alonso R, Soubrie P.
    Synapse; 1991 May 08; 8(1):30-7. PubMed ID: 1714634
    [Abstract] [Full Text] [Related]

  • 18. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ, Tran LP.
    J Pharmacol Exp Ther; 1990 Dec 08; 255(3):1148-57. PubMed ID: 2262898
    [Abstract] [Full Text] [Related]

  • 19. Repeated effects of asenapine on adrenergic and cholinergic muscarinic receptors.
    Choi YK, Wong EH, Henry B, Shahid M, Tarazi FI.
    Int J Neuropsychopharmacol; 2010 Apr 08; 13(3):405-10. PubMed ID: 19835670
    [Abstract] [Full Text] [Related]

  • 20. Chronic ethanol exposure increases 3H-GABA release in rat hippocampus by presynaptic muscarinic receptor modulation.
    Hu M, Walker DW, Vickroy TW, Peris J.
    Alcohol Clin Exp Res; 1999 Oct 08; 23(10):1587-95. PubMed ID: 10549989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.